4-((1,1-DIOXIDOBENZO(B)THIEN-3(2H)-YLIDENE)METHYL)MORPHOLINE
UNII 8337545GT8

Substance Identification & Data

This profile provides standardized clinical and technical data for 4-((1,1-dioxidobenzo(b)thien-3(2h)-ylidene)methyl)morpholine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8337545GT8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 16958-11-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8337545GT8

CAS Registry Number

16958-11-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

4-((1,1-DIOXIDOBENZO(B)THIEN-3(2H)-YLIDENE)METHYL)MORPHOLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H15NO3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MMOKULXFFZJXIR-LUAWRHEFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

3034579

Unique identification number in the NCBI database of chemical substances.

Substance Type

4-[(1,1-Dioxidobenzo[b]thien-3(2H)-ylidene)methyl]morpholine

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S1(c2c(cccc2)\C(\C1)=C/N3CCOCC3)(=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4-((1,1-dioxidobenzo(b)thien-3(2h)-ylidene)methyl)morpholine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.